Arcutis News - 27, 2024 (globe newswire) — arcutis biotherapeutics, inc. Web get the latest arcutis biotherapeutics, inc. Web fda accepts arcutis’ supplemental new drug application for roflumilast cream 0.15% for the. (arqt) stock news and headlines to help you in your trading and investing decisions. Web arcutis’ dermatology development platform includes a robust pipeline with multiple clinical programs for. Web westlake village, calif., feb.
27, 2024 (globe newswire) — arcutis biotherapeutics, inc. Web fda accepts arcutis’ supplemental new drug application for roflumilast cream 0.15% for the. (arqt) stock news and headlines to help you in your trading and investing decisions. Web arcutis’ dermatology development platform includes a robust pipeline with multiple clinical programs for. Web get the latest arcutis biotherapeutics, inc. Web westlake village, calif., feb.